17-44911429-C-T
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PP3_ModerateBS1_SupportingBS2
The NM_002055.5(GFAP):c.934G>A(p.Glu312Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000112 in 1,610,918 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_002055.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GFAP | NM_002055.5 | c.934G>A | p.Glu312Lys | missense_variant | Exon 6 of 9 | ENST00000588735.3 | NP_002046.1 | |
GFAP | NM_001363846.2 | c.934G>A | p.Glu312Lys | missense_variant | Exon 6 of 10 | NP_001350775.1 | ||
GFAP | NM_001242376.3 | c.934G>A | p.Glu312Lys | missense_variant | Exon 6 of 7 | NP_001229305.1 | ||
GFAP | NM_001131019.3 | c.934G>A | p.Glu312Lys | missense_variant | Exon 6 of 8 | NP_001124491.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152234Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000402 AC: 10AN: 248618Hom.: 0 AF XY: 0.0000446 AC XY: 6AN XY: 134602
GnomAD4 exome AF: 0.00000960 AC: 14AN: 1458684Hom.: 0 Cov.: 33 AF XY: 0.00000965 AC XY: 7AN XY: 725488
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152234Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74382
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant summary: GFAP c.934G>A (p.Glu312Lys) results in a conservative amino acid change located in the Intermediate filament, rod domain (IPR039008) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-05 in 248618 control chromosomes (gnomAD). c.934G>A has been reported in the literature in an individual affected with Alexander Disease as a de novo variant (Bonthius_2016). These data do not allow any conclusion about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 26719496). ClinVar contains an entry for this variant (Variation ID: 1406033). Based on the evidence outlined above, the variant was classified as uncertain significance. -
GFAP-related disorder Uncertain:1
The GFAP c.934G>A variant is predicted to result in the amino acid substitution p.Glu312Lys. This variant was reported as de novo in a single patient with Alexander disease, although information on confirmation of parentage was not presented (Bonthius et al. 2016. PubMed ID: 26719496; Heshmatzad et al 2021. PubMed ID: 34146839). This variant is reported in 0.029% of alleles in individuals of Latino descent in gnomAD, representing 10 heterozygous individuals of unknown but presumably unaffected phenotype (http://gnomad.broadinstitute.org/variant/17-42988797-C-T). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
not provided Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on GFAP protein function. ClinVar contains an entry for this variant (Variation ID: 1406033). This missense change has been observed in individual(s) with Alexander disease (PMID: 26719496). In at least one individual the variant was observed to be de novo. This variant is present in population databases (rs763868966, gnomAD 0.03%). This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 312 of the GFAP protein (p.Glu312Lys). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at